MAP1LC3A and gastric cancer: We also confirmed that CPX treatment dramatically decreased proliferation (Ki67 staining) and increased autophagy (LC3 staining) compared to 0.9% NaCl treatment, while decreasing total STAT3 and p-STAT3 (Tyr705) levels in GC xenograft tumors (Fig. 6E).